EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...
It is a fictional representation created for illustrative purposes only. EU antitrust regulators are soliciting feedback from ...
Halozyme intends to purchase all the shares of Evotec at 11 euros per share, which represents a premium of 27.5% to Evotec's last close price. U.S.-listed shares of Evotec were up 6.3%, while those of ...
German drugmaker Evotec is attracting takeover interest from U.S.-based Halozyme Therapeutics , Bloomberg News reported on Thursday.
The Series D financing will support the clinical development of two ADCs.
The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September and, according to ...
Renaissance Technologies took new stakes in Micron Technology (NASDAQ:MU), Eli Lilly (NYSE:LLY), and Cisco Systems ...
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
A smart beta exchange traded fund, the FlexShares International Quality Dividend ETF (IQDF) debuted on 04/12/2013, and offers broad exposure to the World ETFs category of the market.
Renaissance Technologies, founded by the late Jim Simons, cuts its Tesla and Nvidia stakes while raising its GameStop ...
Hosted on MSN50m
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changingIn case you’ve missed it, ASX COVID-era tech darling Bigtincan Holdings (ASX:BTH) has received a takeover offer from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback